RKTO Stock Research Snapshot: Pipeline, Catalysts, and Cash Runway

Rocket One Inc | Needs refresh | Last updated: 2026-06-01T17:55:29Z

TickerRKTO

Market Cap25.6M

Cash RunwayRunway < 6 months

Next Catalyst2028-04

Public Research Snapshot

Rocket One Inc is a publicly tracked healthcare company. This research snapshot summarizes public information on pipeline assets, clinical trials, upcoming catalysts, SEC filings, and cash runway estimates for Rocatinlimab in Atopic Dermatitis (Phase 3).

Pipeline

Asset	Indication	Modality	Stage	Public Note
HT-001	n/a	n/a	n/a	Public pipeline row
RP-A501	Danon Disease	Gene Therapy	Phase 2	Public pipeline row
Rocatinlimab	Atopic Dermatitis	n/a	Phase 3	Public pipeline row
RRx-001	Colorectal Neoplasms	n/a	Phase 2	Public pipeline row

Catalyst Preview

Company	Ticker	Catalyst	Timing	Asset	Confidence
		Clinical Trial Completion	2028-04	RP-A501	Low
		Clinical Trial Completion	2029-06	n/a	Low

Cash Runway Preview

Estimated cash runway: Runway < 6 months.

This is an automated estimate and may differ from company guidance.

Recent SEC Filings

No public filing rows are loaded yet.

Clinical Trial Activity

NCT ID	Phase	Status	Enrollment	Primary Completion
NCT02096354	Phase 2	COMPLETED	62	2018-04-13
NCT03882437	Phase 1	UNKNOWN	7	2025-03-24
NCT05882877	Phase 3	ACTIVE_NOT_RECRUITING	2621	2026-06-22
NCT06092034	Phase 2	RECRUITING	14	2028-04
NCT07137338	Phase 1	RECRUITING	8	2029-06

Scientific Context

catalyst_date_estimated | 2029-06
catalyst_type | Clinical Trial Completion
literature_publication | LuRa: Efficacy and Safety of Radium-223 Following [(177)Lu]Lu-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer.
literature_publication | Subgroups and Special Populations in Heart Failure Clinical Trials: Insights From the HFC-ARC Expert Consensus Panel.
literature_publication | Healthcare Resource Utilization and Cost After Temperature-Controlled Radiofrequency Treatment of Nasal Airway Obstruction: A Real-World Longitudinal Claims Analysis.

Want the full RKTO research brief?

Subscribe for source-linked catalyst analysis, cash runway monitoring, and clinical trial change alerts.

Get the weekly biotech catalyst watchlist

This page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell securities. Data may be incomplete or delayed. Cash runway and catalyst timing estimates are derived from public sources and may differ from company guidance.